Liver transplantation using suboptimal grafts: Impact of donor harvesting technique

Liver Transplantation

Volumn 13, Issue 10, 2007, Pages 1444-1450

  D'Amico, Francesco ^a   Vitale, Alessandro ^b   Gringeri, Enrico ^a   Valmasoni, Michele ^a   Carraro, Amedeo ^a   Brolese, Alberto ^a   Zanus, Giacomo ^a   Boccagni, Patrizia ^a   D'Amico, Davide Francesco ^a   Cillo, Umberto ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b VENETO INSTITUTE OF ONCOLOGY IOV IRCCS   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; GAMMA GLUTAMYLTRANSFERASE;

ADULT; ALCOHOL LIVER DISEASE; AMINOTRANSFERASE BLOOD LEVEL; ARTERY PERFUSION; ARTICLE; BILIRUBIN BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GRAFT DYSFUNCTION; GRAFT RECIPIENT; GRAFT SURVIVAL; HEPATITIS B; HEPATITIS C; HUMAN; INTERMETHOD COMPARISON; LIVER CELL CARCINOMA; LIVER GRAFT; LIVER PERFUSION; LIVER TRANSPLANTATION; MALE; MESENTERIC VEIN; ORGAN DONOR; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; REOPERATION; SPLENIC VEIN; SURGICAL MORTALITY; SURGICAL TECHNIQUE; SURVIVAL RATE; VEIN BLOOD FLOW;

FOLLOW-UP STUDIES; GRAFT SURVIVAL; HEPATECTOMY; HUMANS; HYPOTHERMIA, INDUCED; LIVER FAILURE, ACUTE; LIVER TRANSPLANTATION; MIDDLE AGED; PERFUSION; PROSPECTIVE STUDIES; SURVIVAL RATE; TIME FACTORS; TISSUE AND ORGAN HARVESTING; TISSUE AND ORGAN PROCUREMENT; TREATMENT OUTCOME;

EID: 35448985309     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.21268     Document Type: Article

References (30)

1. Harper AM, Edwards EB, Eleison MD. The OPTN waiting list, 1988-2000. Clin Transplant 2001;73-85.
2. Pokorny H, Langer F, Herkner H, Schemberger R, Plochi W, Soliman T, et al. Influence of cumulative number of marginal donor criteria on primary organ dysfunction in liver recipients. Clin Transplant 2005;19:532-536.
3. Starzl T, Hakala T, Shaw B, Hardesty RL, Rosenthal TJ, Griffith BP, et al. A flexible procedure for multiple cadaveric organ procurement. Surg Gynecol Obstet 1984;158: 223-230.
4. de Ville de Goyet J, Hausleithner V, Malaise J, Reding R, Lerut J, Jamart J, et al. Liver procurement without in situ portal perfusion. A safe procedure for more flexible multiple organ harvesting. Transplantation 1994;57:1328-1332.
5. Imamura H, Sutto F, Brault A, Huet PM. Role of Kupffer cells in cold ischemia/reperfusion injury of rat liver. Gastroenterology 1995;109:189-197.
6. Ploeg RJ, D'Alessandro A, Knechtle SJ, Stegall MD, Pirsch JD, Hoffmann RM, et al. Risk factors for primary dysfunction after liver transplantation - a multivariate analysis. Transplantation 1993;55:807-813.
7. Strasberg SM, Howard TD, Molmenti EP, Hertl M. Selecting the donor liver: risk factors for poor function after orthotopic liver transplantation. Hepatology 1994;20:829-838.
8. Doyle HR, Marino IR, Jabbour N, Zetti G, McMichael J, Mitchell S, et al. Early death or retransplantation in adults after orthotopic liver transplantation. Transplantation 1994;57:1028-1036.
9. Avolio AW, Agnes S, Chirico ASA, Castagneto M. Primary dysfunction after liver transplantation: donor or recipient fault? Transplant Proc 1999;31:434-436.
10. Bilbao I, Charco R, Hidalgo E, Lazaro JL, Balsells J, Murio E, Margarit C. Risk factors for severe ischemic injury after liver transplantation. Transplant Proc 1997;29:368-370.
11. Pokorny H, Gruenberger T, Soliman T, Rockenschaub S, Langle F, Steininger R. Organ survival after primary dysfunction of liver grafts in clinical orthotopic liver transplantation. Transplant Int 2000;13(Suppl):S154-S157.
12. Cavallari A, Cillo U, Nardo B, Filipponi F, Gringeri E, Montalti R, et al. A multicenter pilot prospective study comparing Celsior and University of Wisconsin preserving solutions for use in liver transplantation. Liver Transpl 2003;9:814-821.
13. Moore D, Feurer ID, Speroff T, Gorden DL, Wright JK, Chari RS, Pinson W. Impact of donor, technical, and recipient risk factors on survival and quality of life after liver transplantation. Arch Surg 2005;140:273-277.
14. Brown RS, Rush SH, Rosen HR, Langnas AN, Klintmalm GB, Hanto DW, et al. Liver and intestine transplantation. Am J Transplant 2004:4(Suppl 9):81-92.
15. Renz JF, Kin C, Kinkhabwala M, Jan D, Varadarajan R, Goldstein M, et al. Utilization of extended donor criteria liver allografts maximizes donor use and patient access to liver transplantation. Ann Surg 2005;242:556-565.
16. Briceno J, Marchal T, Padillo J, Solorzano G, Pera C. Influence of marginal donors on liver preservation injury. Transplantation 2002;74:522-526.
17. Briceno J, Solorzano G, Pera C. A proposal for scoring marginal liver grafts. Transplant Int 2000; 13(Suppl 1):249-252.
18. Verran D, Kusyk T, Painter D, Fischer J, Koorey D, Strasser S, et al. Clinical experience gained from the use of 120 steatotic donor livers for orthotopic liver transplantation. Liver Transpl 2003;9:500-505.
19. Busquets J, Xiol X, Figueras J, Jaurrieta. E, Torras J, Ramos E, et al. The impact of donor age on liver transplantation: influence of donor age on early liver function and on subsequent patient and graft survival. Transplantation 2001;71:1765-1771.
20. Gabel M, Liden H, Friman S, Wolfbrandt A, Olausson M. Early function of liver grafts preserved with or without portal perfusion. Transplant Proc 2001;33:2527-2528.
21. Tector AJ, Mangus RS, Chestovich P, Vianna R, Fridell JA, Milgrom ML, et al. Use of extended entena livers decreases wait time for liver transplantation without adversely impacting posttransplant survival. Ann Surg 2006;244:439-450.
22. Silberhumer GR, Pokorny H, Hetz H, Herkner H, Rasoul-Rockenschaub S, Soliman T, et al. Combination of extended donor criteria and changes in the model for end-stage liver disease score predict patient survival and primary dysfunction in liver transplantation: a retrospective analysis. Transplantation 2007;83:588-592.
23. Feng S, Goodrich NP, Bragg-Grasham JL, Dykstra DM, Punch JD, DebRoy MA, et al. Characteristics associated with liver graft failure: the concept of a donor risk index. Am J Transpl 2006:6:783-790.
24. Ioannou GN. Development and validation of a model predicting graft survival after liver transplantation. Liver Transpl 2006;12:1594-1606.
25. Burroughs AK, Sabin CA, Rolles K, Delvart V, Karam V, Buckels J, et al. 3-month and 12-month mortality after first liver transplant in adults in Europe: predictive models for outcome. Lancet 2006;367:225-232.
26. Cameron AM, Ghobrial RM, Yersiz H, Farmer DG, Lipshutz GS, Gordon SA, et al. Optimal utilization of donor grafts with extended criteria. A single-center experience in over 1000 liver transplants. Ann Surg 2006;243:748-755.
27. Kukan M, Vajdova K, Horecky J, Nagvova A, Mehendale HM, Trnovec T. Effects of blockade of Kupffer cells by gadolinium chloride on hepatobiliary function in cold ischemia - reperfusion injury of rat liver. Hepatology 1997;26:1250-1257.
28. Arai M, Mochida S, Ohno A, Arai S, Fujiwara K. Selective bowel decontamination of recipients for prevention against liver injury following orthotopic liver transplantation: evaluation with rat models. Hepatology 1998;27:123-127.
29. Vajdova K, Smrekova R, Kukan M, Jakubovsky J, van Rooijen N, Horecky J, et al. Endotoxin-induced aggravation of preservation-reperfusion injury of rat liver and its modulation. J Hepatol 2000;32:112-120.
30. Cherqui D, Hingot JL, Humeres. R, Rotman N, Julien M, Fagniez PL. Harvesting of the liver without in situ cannulation of the portal system. J Am Coll Surg 1994:178:622-623.